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Article
To maximize outcome after total ankle replacement (TAR), 
it is imperative to achieve a stable, neutrally aligned, planti-
grade, weight-bearing position of the ankle and hindfoot 
postoperatively.10 Malalignment is major risk factor for 
early failure of TAR,12,14,15,29 and most authors agree that it 
must be corrected either prior to or at the time of joint 
replacement.8,10,12,14-16 Furthermore, patients who develop 
osteoarthritis in the tibiotalar joint often have degenerative 
disease in neighboring joints.16 Subtalar or triple fusion is 
sometimes performed in the setting of TAR to correct defor-
mity and/or address degenerative joint disease in the hind-
foot.13,15,25 When performing a TAR in combination with a 
hindfoot fusion, Frigg et al11 showed the optimal position of 
the hindfoot to be neutral or in minimal varus in relation to 
the mechanical axis of the tibia as determined by a hindfoot 
alignment view radiograph.
Although hindfoot fusion can be a powerful tool to cor-
rect deformity and eliminate pain, the manner in which a 
fused hindfoot affects the survivorship and function of a 
TAR remains unclear.13 There is concern that loss of motion 
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Abstract
Background: Ipsilateral hindfoot arthrodesis in combination with total ankle replacement (TAR) may diminish functional 
outcome and prosthesis survivorship compared to isolated TAR. We compared the outcome of isolated TAR to outcomes 
of TAR with ipsilateral hindfoot arthrodesis.
Methods: In a consecutive series of 404 primary TARs in 396 patients, 70 patients (17.3%) had a hindfoot fusion before, 
after, or at the time of TAR; the majority had either an isolated subtalar arthrodesis (n = 43, 62%) or triple arthrodesis 
(n = 15, 21%). The remaining 334 isolated TARs served as the control group. Mean patient follow-up was 3.2 years (range, 
24-72 months).
Results: The SF-36 total, AOFAS Hindfoot-Ankle pain subscale, Foot and Ankle Disability Index, and Short Musculoskeletal 
Function Assessment scores were significantly improved from preoperative measures, with no significant differences 
between the hindfoot arthrodesis and control groups. The AOFAS Hindfoot-Ankle total, function, and alignment scores 
were significantly improved for both groups, albeit the control group demonstrated significantly higher scores in all 3 scales. 
Furthermore, the control group demonstrated a significantly greater improvement in VAS pain score compared to the 
hindfoot arthrodesis group. Walking speed, sit-to-stand time, and 4-square step test time were significantly improved for 
both groups at each postoperative time point; however, the hindfoot arthrodesis group completed these tests significantly 
slower than the control group. There was no significant difference in terms of talar component subsidence between the 
fusion (2.6 mm) and control groups (2.0 mm). The failure rate in the hindfoot fusion group (10.0%) was significantly higher 
than that in the control group (2.4%; p < 0.05).
Conclusion: To our knowledge, this study represents the first series evaluating the clinical outcome of TARs performed 
with and without hindfoot fusion using implants available in the United States. At follow-up of 3.2 years, TAR performed 
with ipsilateral hindfoot arthrodesis resulted in significant improvements in pain and functional outcome; in contrast to 
prior studies, however, overall outcome was inferior to that of isolated TAR.
Level of Evidence: Level II, prospective comparative series.
Keywords: total ankle replacement, hindfoot arthrodesis, arthritis
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in the hindfoot and/or talonavicular joint places abnormal 
stress on the ankle joint and will thus lead to increased early 
wear or degeneration of an ankle prosthesis.7,9,16,19,22 
Furthermore, any compromise of the vascularity of the talus 
could lead to early component subsidence and malposi-
tion.16 Finally, there is no consensus as to the timing of 
these procedures, either staged or synchronous, or whether 
triple arthrodeses confer a greater risk of adverse events 
than less complete hindfoot fusions.16
One series has shown that at midterm follow-up, hindfoot 
fusion in association with ipsilateral TAR has minimal 
adverse effects with clinical and radiographic outcomes sim-
ilar to that of primary TAR alone.16 This investigation, how-
ever, used components not available in the United States. 
There are currently no published series evaluating the out-
come of implants in this setting that include prostheses 
available in the United States. This study compares the clini-
cal and functional outcome of primary TAR in patients with 
hindfoot arthrodesis to that of patients who had a primary 
TAR without hindfoot fusion using components commer-
cially available in the United States and approved or cleared 
for use by the Food and Drug Administration (FDA).
Methods
After receiving appropriate Institutional Review Board 
approval, we prospectively identified a consecutive series of 
404 primary TARs in 396 patients that occurred between 
June 2007 and June 2011 and were followed for a minimum 
of 2 years. All surgeries were performed at a single institu-
tion by orthopaedic foot and ankle surgeons with previous 
TAR experience. The indication for surgery was severe pain 
in an arthritic tibiotalar joint that had failed appropriate 
nonoperative management. All patients signed informed 
consent prior to study initiation. The INBONE (Wright 
Medical, Arlington, TN, USA), Scandinavian Total Ankle 
Replacement (STAR; Small Bone Innovations, Morrisville, 
NJ, USA), and Salto-Talaris (Tornier, Bloomington, MN, 
USA) third-generation total ankle prostheses were implanted 
at the discretion of the operating surgeon. Only primary 
arthroplasty procedures were included; patients were 
excluded from the study if they were undergoing revision 
procedures or conversions of prior ankle arthrodeses to 
TAR. As in the study by Kim et al,16 to evaluate the effect of 
hindfoot fusion on TAR, all patients who had undergone 
prior midfoot or forefoot fusions were also excluded.
Of the 404 ankle replacements performed, we identified 70 
(17.3%) that had an ipsilateral hindfoot arthrodesis (Table 1): 
43 (62%) had an isolated subtalar arthrodesis, 15 (21%) had a 
triple arthrodesis, 10 (14%) had an isolated talonavicular (TN) 
arthrodesis, 1 had a combined TN/calcaneocuboid arthrodesis, 
and 1 had a combined subtalar/calcaneocuboid arthrodesis. 
The remaining 334 isolated TARs served as the control group. 
Clinical and functional outcomes, gait analyses, complica-
tions, radiographic outcomes, and failure rates were compared. 
Revision arthroplasty requiring removal of one or more metal-
lic components or conversion to ankle arthrodesis was regarded 
as a failure for the purposes of this study.
Mean patient follow-up was 3.2 years (range, 24-72 
months), with average patient age in the control group 62.8 
years compared to 61.5 in the fusion group (Table 2). Age, 
mean follow-up, and body mass index (BMI) were not 
Table 1. Patients With Total Ankle Replacement and Ipsilateral Hindfoot Arthrodesis.
Timing of Arthrodesis in Relation to Total Ankle Replacement (TAR)
Type of Arthrodesis Prior to TAR Simultaneous to TAR Subsequent to TAR
Subtalar (n = 43; 62%) 9 28 6
Triple (n = 15; 21%) 14 1 —
Talonavicular (n = 10; 14%) 1 8 1
Talonavicular/calcaneocuboid (n = 1; 1%) 1 — —
Subtalar/calcaneocuboid (n = 1; 1%) 1 — —
Total (n = 70) 26 37 7
Table 2. Patient Characteristics.
Control 
Group
Fusion 
Group P Value
Patients 334 70  
Follow-up (months) 37.5 ± 15.2 38.4 ± 15.8 .648
Mean age (years) 62.8 ± 11.3 61.5 ± 12.6 .252
Body mass index (kg/m2) 29.5 ± 5.5 28.7 ± 4.7 .256
Male:female ratio 1.00:0.96 1.00:1.06 .706
Primary diagnosis <.001
 a.  Posttraumatic 
arthritis
74.0% 50.0%  
 b. Osteoarthritis 16.4% 17.1%  
 c.  Rheumatoid 
arthritis
3.6% 14.0%  
 d. Other 5.7% 18.5%  
Right:left ankle affected 1.00:0.78 1.00:0.52 .143
Prosthesis .001
 a. STAR 103 (30.8%) 19 (27.1%)  
 b. INBONE 163 (48.9%) 48 (68.6%)  
 c. Salto-Talaris 68 (20.4%) 3 (4.3%)  
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significantly different between the 2 patient groups. The 
most common primary diagnosis in the control group was 
posttraumatic arthritis of the ankle (74%), followed by 
osteoarthritis (16.4%) and rheumatoid arthritis (3.6%), with 
the remainder composed of a variety of other etiologies 
(5.7%). Similarly, posttraumatic arthritis was the primary 
diagnosis in 50.0% of the patients in the hindfoot fusion 
group, followed by osteoarthritis (17.1%), rheumatoid 
arthritis (14.0%), and other etiologies (18.5%). Prosthesis 
choice in the fusion group included 19 (27.1%) STAR, 48 
(68.6%) INBONE, 3 (4.3%) Salto-Talaris; in the control 
group, the distribution was 103 (30.8%) STAR, 163 (48.9%) 
INBONE, and 68 (20.4%) Salto-Talaris.
TARs were performed using a standard operative tech-
nique for each respective implant.1,6,10,23 At the time of 
arthroplasty, any additional procedures required to achieve 
a balanced prosthesis and plantigrade foot, including oste-
otomy, arthrodesis, tendon transfer, or heel cord lengthen-
ing, were performed as deemed necessary by the operating 
surgeon. All patients were evaluated preoperatively at 3 
weeks, 6 weeks, and 3 months postoperatively; clinical out-
come assessments were made at 6 months and 1 year post-
operatively, and annually thereafter.
Patient-Reported Outcomes
Pain was rated using the Visual Analog Scale (VAS), rang-
ing from 0 (no pain) to 100 (maximum pain). The American 
Orthopaedic Foot and Ankle Society (AOFAS) hindfoot-
ankle scoring system17 was used to evaluate function. The 
Short Form–36 (SF-36) was used to assess overall patient 
health, and the Foot and Ankle Disability Index (FADI) and 
Short Musculoskeletal Function Assessment (SMFA) ques-
tionnaires were used to assess patient-reported functional 
limitations.26 The FADI asks 26 questions about activities 
of daily living and has previously been reported in an ankle 
arthritis population.15 The SMFA is a 46-item questionnaire 
divided into the Dysfunction (or Function) index, which 
assesses patient function, and the Bother index, which eval-
uates how much patients are bothered by functional limita-
tions; the metric has been validated for use in patients with 
musculoskeletal disease or injury.26
Functional Outcomes
The functional assessments that were completed were a 5 
repetition sit-to-stand, timed get up and go, the 4-square step 
test, and walking speed. During the sit-to-stand test patients 
were asked to sit in a standard arm chair and then to stand up 
and sit down 5 times as quickly as possible. The patients 
were asked to complete this task 2 times and the average sit-
to-stand time was recorded. For the timed get up and go test, 
patients were asked to start in a seated position in a standard 
arm chair. The patient was then asked to stand up and walk 3 
meters around a piece of tape and then return back to the 
chair and sit down. The patient was asked to complete this as 
quickly as possible safely. The time was recorded from the 
time the patient stood up until they sat back down in the 
chair. Again, this task was completed 2 times and the aver-
age time was used for data analysis. The next functional test 
that was completed was the 4-square step test, which was 
performed using standard techniques that have been previ-
ously described.28 The 4-square step test was completed 2 
times and the average of the 2 times was used for analysis. 
Finally, all subjects were asked to complete a series of 5 
walking trials along a 10 meter walkway. Walking speed was 
recorded during the middle 5 meters of the walk using a 
series of timing gates. The average walking speed was deter-
mined from the 5 walking trials and was used for analysis.
Radiographic Analysis
As previously noted, there is concern that placement of a 
arthroplasty component on a talus previously instrumented 
in a hindfoot arthrodesis may further compromise the vas-
cularity of the talus and lead to early component subsidence 
and malposition.16 A subset of 35 of the 70 ankles in the 
hindfoot arthrodesis group were paired with an exact age-, 
sex-, and implant-matched cohort of 35 ankles in the con-
trol group. To objectively and reproducibly determine the 
position of the talar component in a qualitative manner, we 
used the inferior (plantar) calcaneal border as a fixed refer-
ence point, as other common anatomic features sometimes 
used to assess talar component position such as the calca-
neal tuberosity2 are obliterated in many hindfoot fusions. 
Using the PACS (General Electric; Fairfield, CT, USA) vir-
tual imaging software utilized at our institution, a line was 
drawn along the longitudinal axis of the talar component 
(Figure 1). A perpendicular line was drawn from the exact 
midpoint of this line and extended through the inferior cal-
caneal border. The point at which this crossed the inferior 
calcaneal border was marked, and the distance from this 
point to the midpoint of the longitudinal axis of the talar 
component was measured. This measurement was repeated 
on the weight-bearing radiographs at most recent follow-
up. Any interval decrease in this height was defined as the 
talar component subsidence.
To control for talar component loosening and subsequent 
flexion or extension on the talus, which would thus change 
the position of the reference point on the inferior calcaneal 
border, a modified gamma angle2,3 was also calculated for 
each radiograph. This was calculated by the intersection of 
the long axis of the talar component with a line drawn from 
the posterior talar component through the middle of the 
talar neck (Figure 1). The gamma angle from the immediate 
postoperative radiograph was compared to that on the most 
recent follow-up radiograph to detect any change in sagittal 
plane alignment.
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Statistical Methods
The demographic data were analyzed using an independent 
samples t test to determine if any differences existed in age, 
BMI, or follow-up time between the control group and the 
hindfoot fusion group. To determine if differences existed 
between the operative groups with regard to the operative 
side, gender, and primary diagnosis a chi-square analysis 
was completed. In addition, a series of 2 × 3 repeated mea-
sures ANOVA were completed to determine if any signifi-
cant differences existed between time points (preoperative, 
1-year postoperative, and the most recent follow-up) and 
between the operative groups (control versus hindfoot 
fusion). The level of significance for all tests was set at P < 
.05. Significant differences were then assessed using 
Tukey’s post hoc testing to determine which time points 
were significantly different. All statistical analyses were 
performed using SPSS version 20.0 (Chicago, IL, USA).
Results
Radiographic and clinical evaluation suggested all hindfoot 
arthrodeses progressed to fusion. The SF-36 total and sub-
scales, AOFAS Hindfoot-Ankle Pain subscale, FADI, and 
SMFA Function and Bother index scores were significantly 
improved at the most recent follow-up after TAR compared 
to preoperative assessment (all P values < .001), with no 
significant differences between the hindfoot arthrodesis and 
control groups (Table 3). The SF-36 total score improved 
from 48.6 to 67.4 (P < .001) in the hindfoot fusion group 
compared an increase from 49.7 to 73.1 (P < .001) in the 
control group. The AOFAS Hindfoot-Ankle Pain score 
improved from 11.8 to 29.7 (P < .001) in the hindfoot fusion 
group compared to an improvement of 11.4 to 31.0 (P < 
.001) in the control group. The FADI scores improved from 
0.53 to 0.19 (P < 0.001) in the hindfoot fusion group and 
0.54 to 0.16 (P < .001) in the control group. The SMFA 
Function and Bother index scores improved from 38.2 to 
19.3 and 39.6 to 19.7 in the hindfoot fusion group (both P 
values < .001); they improved from 35.1 to 14.3 and 40.2 to 
16.4 in the control group (both P values < .001).
The AOFAS Hindfoot-Ankle total, function, and align-
ment scores were significantly improved at the most recent 
follow-up for both groups (all P values < .001; Table 3); the 
control group, however, demonstrated significantly higher 
scores than the hindfoot fusion group in all 3 scales. The 
AOFAS total scores improved from 38.1 to 71.0 points in 
the hindfoot fusion group, which was significantly lower 
than the control group improvement of 42.5 to 81.6 (P < 
.001). Similarly, the AOFAS function scores improved from 
24.5 to 42.3 in the hindfoot fusion group compared to 30.9 
to 48.9 in the control group (P < .001). The AOFAS align-
ment score improved from 6.0 to 8.3 in the hindfoot fusion 
group compared to 6.4 to 9.5 in the control group (P = .04).
The control group also demonstrated a significantly 
greater improvement in VAS pain score when compared 
with the hindfoot arthrodesis group at 1 year (P = .009; 
Table 3), and this improvement was maintained through the 
Figure 1. Radiographic analysis of talar component position. (I) To determine component subsidence, a line was drawn along the 
longitudinal axis of the talar component (line AB). The midpoint of this line was calculated (point C). A line perpendicular to line AB 
was drawn from point C to the inferior calcaneal border (line CD). The distance of line CD was compared between the first weight-
bearing postoperative radiographs and the radiographs at most recent follow-up. (II) To determine talar component loosening, the 
angle formed by the longitudinal axis of the talar component and a line drawn from the most posterior aspect of the component 
through the center of the talar neck was calculated (angle γ).
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most recent follow-up assessment (71.2 points preopera-
tively improved to 10.4 for the control group compared to 
65.8 to 18.2 for the fusion group).
With regard to the functional outcomes, walking speed, 
sit-to-stand time, and 4-square step test time, all were sig-
nificantly improved at each postoperative time point for 
each group (P < .05). The hindfoot fusion group, however, 
completed both the sit-to-stand and 4-square step test sig-
nificantly slower than did the control group, independent of 
the time when the testing was completed (P < .001). Finally, 
the hindfoot fusion group demonstrated a significantly 
greater improvement in the timed get up and go test com-
pared to the control group at the 1 year follow-up (P = .027), 
but by the most recent follow-up the times between the 2 
groups were not significantly different.
In the radiographic analysis, there was no significant dif-
ference in mean subsidence of the talar component between 
the control (2.0 mm) and fusion (2.6 mm) groups (P = .334). 
When this was controlled for any change in gamma angle of 
greater or equal to 3.0 degrees, indicating significant loosen-
ing of the component that would compromise the reproduc-
ibility of the fixed reference point on the inferior calcaneal 
border, there remained no significant difference between the 
2 groups in terms of component subsidence (P = .397).
Implant survivorship was significantly different between 
the 2 groups. There were 8 (2.4%) failures in the control 
Table 3. Clinical Outcome Measures After Total Ankle Replacement (TAR).
Hindfoot Fusion 
Group (Mean, SD)
Control Group 
(Mean, SD)
Time × Group 
(P Value)a
Group Differences 
(P Value)
Improvement After 
TAR (P Value)
FADI scoresb
 Preoperative 0.5 (0.1) 0.5 (0.12) .190 .354 <.001
 Most recent follow-up 0.2 (0.2) 0.2 (0.2)  
Short Form–36 Totalb
 Preoperative 48.6 (19.2) 49.7 (16.2) .409 .258 <.001
 Most recent follow-up 67.4 (21.9) 73.1 (19.0)  
Short Form–36 Painb
 Preoperative 37.6 (15.9) 38.0 (15.2) .413 .220 <.001
 Most recent follow-up 66.3 (19.7) 71.6 (21.6)  
Short Form–36 Mental Healthb
 Preoperative 75.9 (18.0) 74.3 (18.6) .305 .708 <.001
 Most recent follow-up 79.5 (14.4) 81.2 (15.7)  
Short Form–36 Physical Functionb
 Preoperative 24.7 (16.3) 26.4 (15.4) .234 .110 <.001
 Most recent follow-up 54.4 (25.2) 63.4 (24.6)  
AOFAS Total scoreb,c
 Preoperative 38.1 (15.5) 42.5 (16.3) .146 <.001 <.001
 Most recent follow-up 70.5 (18.9) 81.6 (12.7)  
AOFAS Pain scoreb
 Preoperative 11.8 (11.3) 11.4 (10.6) .505 .400 <.001
 Most recent follow-up 29.7 (10.5) 31.0 (9.0)  
AOFAS Function scoreb,c
 Preoperative 24.5 (8.6) 30.9 (10.7) .458 <.001 <.001
 Most recent follow-up 42.3 (10.0) 49.8 (6.7)  
AOFAS Alignment scoreb,c
 Preoperative 6.0 (4.2) 6.4 (3.7) .412 .040 <.001
 Most recent follow-up 8.3 (3.2) 9.5 (1.7)  
SMFA Functionb
 Preoperative 38.2 (14.0) 35.1 (11.3) .61 .056 <.001
 Most recent follow-up 19.3 (16.5) 14.3 (12.1)  
SMFA Botherb
 Preoperative 39.6 (17.4) 40.2 (16.9) .356 .452 <.001
 Most recent follow-up 19.7 (19.7) 16.4 (15.9)  
AOFAS, American Orthopaedic Foot and Ankle Society; FADI, Foot and Ankle Disability Index; SMFA, Short Musculoskeletal Function Assessment.
aInteraction between time and group (evaluating if the groups are responding differently over time).
bIndicates a significant difference between time points independent of operative group.
cIndicates a significant difference between operative groups independent of time.
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group (3 deep infections, 5 aseptic failures) compared to 7 
(10.0%, P < .05) in the fusion group (one deep infection and 
6 aseptic failures), requiring removal of the metal compo-
nents and either revision TAR or conversion to ankle 
arthrodesis. Six (85.7%) of the 7 patients in the hindfoot 
fusion group who went on to have a failed TAR were treated 
with tibiotalocaneal arthrodesis as a salvage procedure; 5 
with an intramedullary nail, and 1 with an anterior plate and 
screw construct with a long axial screw placed across the 
tibiotalar and talocalcaneal joints. The remaining patient 
had a tibiotalar arthrodesis with anterior plate and screw 
construct.
Discussion
At follow-up of 3.2 years, TAR performed with ipsilateral 
hindfoot arthrodesis resulted in significant improvements in 
pain and functional outcome, including SF-36, SMFA, 
AOFAS Hindfoot-Ankle, and VAS scores as well as mea-
sures of gait analysis and walking speed. In contrast to the 
prior study by Kim et al,16 however, overall outcome, pain 
relief, and implant survivorship was inferior to that of iso-
lated TAR.
It should be noted that some of the metrics implemented 
may not have been ideally suited to compare those with a 
hindfoot fusion compared to those without a fusion. For 
example, the AOFAS hindfoot and ankle scoring system 
assigns each patient a score from 0 to 6 based on hindfoot 
motion. For patients with a successful hindfoot fusion, they 
are immediately relegated to a maximal score of 94 points 
rather than 100 points as in the case of those with primary 
TAR. Thus, although the hindfoot fusion group showed sig-
nificant improvements in the AOFAS total and function 
scores (total scores improved from 38.1 to 71.0 points and 
function scores improved from 24.5 to 42.3), it may not 
have been fair to compare them to the primary TAR group 
that could conceivably receive 6 more points for hindfoot 
motion (total scores improved from 42.5 to 81.6 and func-
tion scores from 30.9 to 48.9).
There was a significantly higher incidence of rheuma-
toid arthritis in the hindfoot fusion group (14.0%) compared 
to the control group (3.6%), similar to the study by Kim 
et al.16 This can likely be explained at least in part by the 
finding that rheumatoid arthritis tends to affect multiple 
joints, such as the neighboring hindfoot joints. As discussed 
by Kim et al,16 the results of TAR in rheumatoid arthritis 
have been shown to be good27 and not inferior18 to those 
undergoing TAR for primary osteoarthritis, so we assume 
that a slightly different distribution of etiology would not 
seriously compromise our findings.
The rate of mobile-bearing prosthesis implantation 
was similar between the fusion group (27.1%) and the 
control group (30.8%). Although the overall percentage 
of fixed-bearing implants used in the 2 groups was similar 
(72.9% in the fusion group versus 69.3% in the control 
group), there was a higher rate of INBONE prosthesis 
implantation versus the Salto-Talaris prosthesis in the 
fusion group compared to the control group (Table 1). 
Queen et al21 specifically looked at the outcomes of 
patients who received a Salto-Talaris versus INBONE 
fixed-bearing prosthesis, however, and found no signifi-
cant difference in terms of functional outcome or ankle 
range of motion at 2 years between patients who received 
the 2 prostheses.
Of note, all 7 (100%) failures in the hindfoot fusion 
group did have an INBONE prosthesis. The INBONE sys-
tem utilizes an intramedullary referencing system for the 
tibial component positioning which involves drilling 
through the calcaneus, talus, and tibia with a 6-mm drill. 
The intramedullary referencing system can be useful in 
cases of significant deformity associated with degenerative 
disease in the hindfoot. It is conceivable that increased 
instrumentation of the talus with this system may predis-
pose patients to aseptic loosening and early failure in 
patients with an ipsilateral hindfoot fusion. Alternatively, it 
may be that the INBONE system was selected preferen-
tially in cases of significant hindfoot deformity and thus 
these patients may have been at an inherently higher risk for 
early failure in this study.
Some authors16 have suggested a 2-stage approach for 
patients requiring a subtalar and/or hindfoot fusion in con-
junction with TAR. Specifically, there is concern that a 
1-stage procedure will lead to higher rates of avascular 
necrosis of the talus due to aggressive denuding and devas-
cularization of the sinus tarsi and lead to early talar compo-
nent subsidence, malposition, and subsequent implant 
failure. We did not have sufficient patient numbers to per-
form a statistical analysis of whether timing of hindfoot 
arthrodesis in relation to total ankle implantation affected 
outcome and thus cannot make a recommendation as to 
whether the procedures should be staged or simultaneously 
performed. In this series, of the 7 patients in the fusion 
group who were considered failures, 2 (28.6%) had hind-
foot fusions prior to TAR, 3 (42.8%) had hindfoot fusions at 
the time of TAR, and 2 (28.6%) had a hindfoot fusion after 
TAR implantation. Kim et al16 demonstrated a tendency 
toward higher soft tissue scarring and bony impingement 
with staged procedures but a higher rate of instability or 
dislocation of the polyethylene component with simultane-
ous procedures. At midterm follow-up in this study, how-
ever, there was no significant difference in terms of 
radiographic talar component subsidence in the hindfoot 
fusion group compared to the control group at 2 years. More 
longitudinal follow-up studies may be necessary to support 
this finding.
We did demonstrate a significantly lower survivorship 
rate in the fusion group (90.0%) compared to the control 
group (97.6%) at 3.2-year follow-up. On the basis of 
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current literature, survivorship of total ankle arthroplasty 
implants, when measured as the retention of metal compo-
nents, ranges from 70% to 98% at 3 to 6 years, and 80% to 
95% at 8 to 12 years.8 High survivorship of the STAR and 
Salto-Talaris implants have been recently reported at 93.9% 
at 5 years20 and 96.0% at 2.8 years,24 respectively, with 
marked improvement of pain, function, and quality-of-life 
measures;20,24 there are no published studies evaluating the 
survivorship of INBONE prostheses at similar length fol-
low-up to date. The survivorship of both groups in this 
study is consistent with results reported in the recent litera-
ture. Although the rate was significantly higher in the con-
trol group, it should be noted that the patients in this group 
likely represent a more ideal patient cohort to undergo TAR, 
as they do not have significant deformity and/or neighbor-
ing joint disease requiring a hindfoot arthrodesis, and it is 
not surprising their overall survivorship is superior to the 
fusion group.
This investigation has highlighted several important 
directions for future research. There is a concern that plac-
ing a total ankle prosthesis in the setting of a fused hindfoot 
will create abnormal stresses on the ankle joint and will 
thus lead to increased early wear or degeneration of the 
implant. One of the prostheses used in this study, the STAR 
total ankle, is a mobile-bearing design, compared to the 
fixed-bearing components of the INBONE and Salto-
Talaris. The STAR was only recently approved by the FDA 
in 2009, and it remains the only mobile-bearing implant 
currently available in the United States. It is possible that 
the nonconstrained design of the STAR prosthesis will pro-
vide improved motion, outcome, and ultimately survivor-
ship in the setting of a fused hindfoot. In a replaced ankle, 
the flat bearing surfaces between the tibial component and 
polyethylene insert allow some rotation in a mobile-bear-
ing design, and authors have speculated that this may play 
an important role in the transfer of rotational movement 
from the tibia into calcaneal inversion/eversion in patients 
with a fused hindfoot,4,16 although there are currently no 
data to support this theory. As more patients receive the 
STAR implant, it will be important to perform a subgroup 
analysis of this study comparing the outcome of those with 
mobile-bearing implants versus those with traditional 
fixed-bearing implants.
Important strengths of this investigation include a large 
consecutive sample size, relatively long follow-up at 3.2 
years compared to other studies, and comprehensive longi-
tudinal clinical and functional outcome assessments. There 
are, however, several key limitations to this study. We 
lacked a sufficient number of patients with at least 2-year 
follow-up who had received the STAR necessary for a sub-
group analysis comparing mobile- to fixed-bearing TARs in 
patients with ipsilateral hindfoot fusion. This comparison 
may provide key information for clinical decisions in the 
future, particularly since our data suggests overall clinical 
outcome is slightly inferior compared to that of isolated pri-
mary TAR. The use of both fixed- and mobile-bearing 
implants in this study conceivably could explain the dispar-
ity between our findings and those published by Kim et al16 
demonstrating equivalent outcome between patients with a 
hindfoot fusion and primary TAR; in that study all patients 
received the mobile-bearing Hintegra prosthesis available 
in Europe (Newdeal SA, Lyon, France). Finally, it should be 
noted that in this study all patients with a hindfoot arthrod-
esis were deemed to have achieved bony union on the basis 
of clinical examination and radiographic analysis. Coughlin 
et al5 demonstrated in a series of hindfoot arthrodeses that 
standard radiographs substantially overestimate the rate of 
hindfoot fusion when compared to computed tomography 
(CT) and showed CT scans are significantly more reliable 
in determining bony union. Given that radiographs were 
used as the sole imaging modality to assess union in our 
patients, it is possible that some patients in the fusion group 
had unappreciated nonunions that may have served as a 
confounding factor.
In summary, at a follow-up of 3.2 years, TAR performed 
with ipsilateral hindfoot arthrodesis results in significant, 
predictable improvements in pain, function, and quality of 
life with acceptable failure rates consistent with those pub-
lished in the literature.8 When indicated, therefore, hindfoot 
arthrodesis may safely be performed in conjunction with 
TAR. Importantly, however, in contrast to prior studies, we 
have shown that overall clinical outcome and implant survi-
vorship is slightly inferior to that of isolated primary 
TAR.8,20,24 Given the relatively short follow-up of this 
investigation, a more comprehensive longitudinal assess-
ment is needed to assess long-term outcomes in this patient 
cohort.
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